The effect of the "Nocardia lysozyme digest" (NLD) obtained from Nocardia opaca on the Epirubicine accumulation in erythrocytes was studied by flow cytometry. It was shown that the number of fluorescent cells increased under the NLD action due to the increased membrane permeability for epirubicine. An opposite effect was also recorded consisting in the decrease of the relative fluorescence intensity per cell. This effect was attributed to the fluorescence quenching by the oxygen metabolites produced by NDL. In this paper we present some results of the study of the NLD effect on the epirubicine (Epir) accumulation in the erythrocytes (E). It is shown by flow cytometry that the Epir accumulation in the red cells is modified by the presence of the NLD fraction.

Download full-text PDF

Source

Publication Analysis

Top Keywords

epirubicine accumulation
8
nocardia opaca
8
accumulation erythrocytes
8
flow cytometry
8
epir accumulation
8
flow cytometric
4
cytometric study
4
epirubicine
4
study epirubicine
4
accumulation
4

Similar Publications

Bladder instillation of chemo-therapeutic agents is common for bladder cancer (BC) treatment, however, due to the poor tissue selectivity of chemotherapeutic agents, this method suffers from bladder irritation or even chemical cystitis. Here, we designed a hydroxyethyl starch-based prodrug for epirubicin (EPI) using a pH-sensitive hydrazone linker and folate as the active targeting moiety (FA-HES-hyd-EPI) to achieve delivery selectivity. Prodrug micelles decorated with FA (FA-m), with diameter of 203.

View Article and Find Full Text PDF

Cancer cells possess an efficient redox system, enabling them to withstand oxidative damage induced by treatments, especially in hypoxia areas and ferroptosis can disrupt redox homeostasis in cancer cell. Herein, GSH-sensitive nanoparticles are constructed that induce ferroptosis by long-lasting GSH depletion and enhanced PDT. Carbonic anhydrase IX inhibitor, protoporphyrin IX (Por) complexed with Fe and epirubicin (EPI) are grafted to hyaluronic acid (HA) via disulfide bonds to obtain HSPFE and loaded xCT inhibitor SAS for fabricating SAS@HSPFE which is actively targeted to deep hypoxic tumor cells, and explosively releasing EPI, Por-Fe complex and SAS due to at high GSH concentration.

View Article and Find Full Text PDF

US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy.

J Nanobiotechnology

October 2024

State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, 1 Yixueyuan Rd, Yuzhong District, Chongqing, 400016, China.

Article Synopsis
  • Focused ultrasound ablation surgery (FUAS) is a minimally invasive treatment for tumors, but it faces challenges like low safety, efficiency, and issues with post-surgery tumor remaining.
  • This study developed a new system using gas-producing genetically modified E.coli to enhance ultrasound imaging and treatment efficiency by specifically targeting tumor areas with low oxygen levels.
  • The research also introduced multifunctional nanoparticles that provide combined ultrasound treatment, chemotherapy, and imaging, leading to improved tumor eradication and addressing the shortcomings of existing FUAS methods.
View Article and Find Full Text PDF

Metabolic reprogramming is a hallmark of cancer, and abnormal lipid metabolism is associated with drug resistance in bladder cancer cells. The long noncoding RNA (lncRNA) UCA1 is overexpressed in bladder cancer, but its functional contribution to lipid metabolism remains uncharacterized. In this study, we demonstrated that lncRNA UCA1 inhibits epirubicin-induced cell apoptosis by supporting abnormal lipid metabolism in bladder cancer cells.

View Article and Find Full Text PDF
Article Synopsis
  • Epirubicin (EPI) is an effective cancer treatment but causes harmful heart toxicity through ferroptosis, which is linked to iron imbalance in cells.
  • Research showed that inhibiting ferroptosis with Ferrostatin-1 can reduce this heart damage.
  • The study identified ATP6V0A2 as a key molecule in protecting against EPI-induced heart damage by restoring lysosomal function and reducing oxidative stress, suggesting it as a potential treatment target.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!